Terns Pharmaceuticals Inc (TERN)
5.44
+0.15
(+2.84%)
USD |
NASDAQ |
May 03, 16:00
5.435
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Cash from Operations (Quarterly): -19.32M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -19.32M |
| September 30, 2023 | -20.70M |
| June 30, 2023 | -12.99M |
| March 31, 2023 | -14.38M |
| December 31, 2022 | -11.21M |
| September 30, 2022 | -13.44M |
| June 30, 2022 | -11.16M |
| March 31, 2022 | -13.30M |
| Date | Value |
|---|---|
| December 31, 2021 | -10.67M |
| September 30, 2021 | -8.082M |
| June 30, 2021 | -8.76M |
| March 31, 2021 | -14.32M |
| December 31, 2020 | -7.387M |
| September 30, 2020 | -6.313M |
| June 30, 2020 | -8.822M |
| March 31, 2020 | -7.287M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-20.70M
Minimum
Sep 2023
-6.313M
Maximum
Sep 2020
-11.76M
Average
-11.19M
Median
Cash from Operations (Quarterly) Benchmarks
| Viking Therapeutics Inc | -6.134M |
| Eli Lilly and Co | 1.166B |
| Pfizer Inc | 5.24B |
| Amgen Inc | 689.00M |
| Madrigal Pharmaceuticals Inc | -79.93M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 47.23M |
| Cash from Financing (Quarterly) | 13.86M |
| Free Cash Flow | -67.44M |
| Free Cash Flow Per Share (Quarterly) | -0.2676 |
| Free Cash Flow Yield | -17.40% |